Real-time enrollment status for this thyroid eye disease clinical trial
Current Status
Terminated
Checked: June 2, 2026 at 3:46 AM UTC
| NCT Number | NCT05517447 |
| Recruiting Status | Terminated |
| Condition | Thyroid Eye Disease |
| Phase | Clinical Trial |
| Target Enrollment | 180 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Immunovant Sciences GmbH |
| Last Updated on CT.gov | April 29, 2026 (Apr 29, 2026) |
As of June 2, 2026: Clinical trial NCT05517447 is currently terminated participants. This clinical trial study for thyroid eye disease is not currently accepting new participants at 9 locations across the United States. The study is sponsored by Immunovant Sciences GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05517447 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05517447 was last updated Apr 29, 2026 (April 29, 2026). HelloStudys verifies this status automatically.